Personal information

No personal information available

Activities

Collapse all

Employment (1)

University of Cambridge: Cambridge, GB

2013-08-01 to present | Professor of Stroke Medcine (Clinical Neurosciences)
Employment
Source: Self-asserted source
Hugh Stephen Markus

Education and qualifications (3)

University of Oxford: Oxford, GB

BM BcH (Clinical Medicine)
Education
Source: Self-asserted source
Hugh Stephen Markus

University of Oxford: Oxford, GB

DM (Clinical Medicine)
Education
Source: Self-asserted source
Hugh Stephen Markus

University of Cambridge: Cambridge, GB

BA (Experimental Psychology)
Education
Source: Self-asserted source
Hugh Stephen Markus

Funding (4)

Understanding novel disease processes underlying cerebral small vessel disease and determining whether they can be therapeutically modified

2016-10-02 to 2022-10-31 | Grant
Medical Research Council (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.6501936
GRANT_NUMBER: MR/N026896/1
Source: Self-asserted source
Hugh Stephen Markus via DimensionsWizard

Apathy in stroke and cerebral small vessel disease- towards better understanding and more effective treatment approaches

2016-01-01 to 2021-01-01 | Grant
Stroke Association (Northampton, GB)
URL: https://app.dimensions.ai/details/grant/grant.6425083
GRANT_NUMBER:

PPA 2015/02
Source: Self-asserted source
Hugh Stephen Markus via DimensionsWizard

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial

2015-01-01 to 2020-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
URL: https://app.dimensions.ai/details/grant/grant.7877115
GRANT_NUMBER: 1079696
Source: Self-asserted source
Hugh Stephen Markus via DimensionsWizard

What causes lacunar stroke? A 7T magnetic resonance imaging study

Grant
British Heart Foundation (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.9309239
GRANT_NUMBER: PG/19/74/34670
Source: Self-asserted source
Hugh Stephen Markus via DimensionsWizard

Works (6)

Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A Review.

JAMA neurology
2022-11-01 | Journal article
DOI: 10.1001/jamaneurol.2022.2262
PMID: 35969390
Contributors: Hugh Stephen Markus; Markus HS; van Der Flier WM; Smith EE; Bath P; Biessels GJ; Briceno E; Brodtman A; Chabriat H; Chen C et al.
Source: Self-asserted source
Hugh Stephen Markus

PRESERVE: Randomized Trial of Intensive Versus Standard Blood Pressure Control in Small Vessel Disease.

Stroke
2021-05-28 | Journal article
DOI: 10.1161/strokeaha.120.032054
PMID: 34044580
Contributors: Hugh Stephen Markus; Markus HS; Egle M; Croall ID; Sari H; Khan U; Hassan A; Harkness K; MacKinnon A; O'Brien JT et al.
Source: Self-asserted source
Hugh Stephen Markus

Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results.

JAMA neurology
2019-06-01 | Journal article
DOI: 10.1001/jamaneurol.2019.0072
PMID: 30801621
PMC: PMC6563567
Contributors: Hugh Stephen Markus; Markus HS; Christopher Levi; King A; Madigan J; Norris J; Cervical Artery Dissection in Stroke Study (CADISS) Investigators
Source: Self-asserted source
Hugh Stephen Markus

Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis.

The Lancet. Neurology
2019-05-23 | Journal article
DOI: 10.1016/s1474-4422(19)30149-8
PMID: 31130429
Contributors: Hugh Stephen Markus; Markus HS; Eric L Harshfield; Compter A; Kuker W; Kappelle LJ; Clifton A; van der Worp HB; Rothwell P; Algra A et al.
Source: Self-asserted source
Hugh Stephen Markus

Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis.

JAMA neurology
2019-01-01 | Journal article
DOI: 10.1001/jamaneurol.2018.3122
PMID: 30422209
PMC: PMC6439887
Contributors: Hugh Stephen Markus; stephanie debette; Schilling S; Duperron MG; Larsson SC; Markus HS
Source: Self-asserted source
Hugh Stephen Markus

Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial.

The Lancet. Neurology
2015-02-12 | Journal article
DOI: 10.1016/s1474-4422(15)70018-9
PMID: 25684164
Contributors: Hugh Stephen Markus; CADISS trial investigators; Markus HS; Hayter E; Levi C; Feldman A; Venables G; Norris J
Source: Self-asserted source
Hugh Stephen Markus
How many people are using ORCID?